Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

Autor: Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I, GQM05 Study Group

Publikováno v: Vaccine
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Background: A quadrivalent split-virion inactivated influenza vaccine (VaxigripTetre (TM), Sanofi Pasteur; IIV4) containing two A strains (H1N1 and H3N2) and B strains from both lineages (Victoria and Yamagata) was approved in Europe in 2016 for indi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1db908618342213f93474474477d894d
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2722

Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia.

Autor: Lang JE; From the Department of Pediatrics.; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina., Hornik CP; From the Department of Pediatrics.; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina., Elliott C; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina., Silverstein A; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina., Hornik C; From the Department of Pediatrics.; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina., Al-Uzri A; Oregon Health and Science University, Portland, Oregon., Bosheva M; Medical University, Plovdiv, Bulgaria., Bradley JS; Rady Children's Hospital, the University of California San Diego, San Diego, California., Borja-Tabora CFC; Research Institute for Tropical Medicine, Manila, Philippines., Di John D; Kirk Kerkorian School of Medicine at UNLV, Las Vegas, Nevada., Mendez Echevarria A; Pediatric Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Madrid, Spain., Ericson JE; Penn State College of Medicine, Hershey, Pennsylvania., Friedel D; Virginia Commonwealth University Medical Center, Richmond, Virginia., Gonczi F; University of Debrecen Clinical Center Infectology Clinic, Debrecen, Hungary., Isidro MGD; West Visayas State University Medical Center, Iloilo City, Philippines., James LP; Arkansas Children's Hospital Research Institute, Little Rock, Arkansas., Kalocsai K; Dél-pesti Centrumkórház Országos Hematológiai és Infektológiai Intézet, Budapest, Hungary., Koutroulis I; Children's National Hospital, Washington, DC., Laki I; Pulmonary Hospital, Törökbálint, Hungary., Ong-Lim ALT; Philippine General Hospital, University of the Philippines Manila, Philippines., Nad M; Kanizsai Dorottya Hospital, Nagykanizsa, Hungary., Simon G; Fejér County Szent György University Teaching Hospital, Székesfehérvár, Hungary., Syed S; East Carolina University, Brody School of Medicine, Greenville, North Carolina., Szabo E; Csolnoky Ferenc Hospital, Veszprém, Hungary., Benjamin DK Jr; From the Department of Pediatrics.; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina., Cohen-Wolkowiez M; From the Department of Pediatrics.; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2022 Jul 01; Vol. 41 (7), pp. 556-562. Date of Electronic Publication: 2022 Jun 07.